ArticleJournal of ovarian research2013

PRIMA-1 increases cisplatin sensitivity in chemoresistant ovarian cancer cells with p53 mutation: a requirement for Akt down-regulation.

Noriko Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.